ABOS
Price
$1.41
Change
+$0.05 (+3.68%)
Updated
Aug 11, 11:20 AM (EDT)
Capitalization
82.38M
One day until earnings call
ACHV
Price
$2.51
Change
+$0.01 (+0.40%)
Updated
Aug 11, 11:23 AM (EDT)
Capitalization
124.21M
87 days until earnings call
Interact to see
Advertisement

ABOS vs ACHV

Header iconABOS vs ACHV Comparison
Open Charts ABOS vs ACHVBanner chart's image
Acumen Pharmaceuticals
Price$1.41
Change+$0.05 (+3.68%)
Volume$200
Capitalization82.38M
Achieve Life Sciences
Price$2.51
Change+$0.01 (+0.40%)
Volume$1.8K
Capitalization124.21M
ABOS vs ACHV Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. ACHV commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and ACHV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (ABOS: $1.36 vs. ACHV: $2.50)
Brand notoriety: ABOS and ACHV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 27% vs. ACHV: 81%
Market capitalization -- ABOS: $82.38M vs. ACHV: $124.21M
ABOS [@Biotechnology] is valued at $82.38M. ACHV’s [@Biotechnology] market capitalization is $124.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileACHV’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • ACHV’s FA Score: 0 green, 5 red.
According to our system of comparison, ABOS is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 3 TA indicator(s) are bullish while ACHV’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 3 bullish, 5 bearish.
  • ACHV’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +0.74% price change this week, while ACHV (@Biotechnology) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.49%. For the same industry, the average monthly price growth was +31.98%, and the average quarterly price growth was +19.31%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 12, 2025.

ACHV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+22.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($124M) has a higher market cap than ABOS($82.4M). ABOS YTD gains are higher at: -20.930 vs. ACHV (-28.977). ACHV has higher annual earnings (EBITDA): -44.37M vs. ABOS (-111.98M). ABOS has more cash in the bank: 149M vs. ACHV (23.2M). ACHV has less debt than ABOS: ACHV (9.96M) vs ABOS (29M). ABOS (0) and ACHV (0) have equivalent revenues.
ABOSACHVABOS / ACHV
Capitalization82.4M124M66%
EBITDA-111.98M-44.37M252%
Gain YTD-20.930-28.97772%
P/E RatioN/AN/A-
Revenue00-
Total Cash149M23.2M642%
Total Debt29M9.96M291%
FUNDAMENTALS RATINGS
ACHV: Fundamental Ratings
ACHV
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSACHV
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 5 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRLBF0.750.07
+9.79%
Cresco Labs Inc.
ALOD0.08N/A
N/A
Allied Resources, Inc.
BGAOF9.98N/A
N/A
Proximus Group
SYIEF92.44N/A
N/A
Symrise Ag
AMQFF0.18N/A
-0.24%
ABITIBI METALS CORP.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-4.23%
CRBU - ABOS
49%
Loosely correlated
-4.42%
GLSI - ABOS
47%
Loosely correlated
+4.37%
FHTX - ABOS
47%
Loosely correlated
-8.03%
BEAM - ABOS
47%
Loosely correlated
-1.34%
KYTX - ABOS
47%
Loosely correlated
-2.11%
More

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been closely correlated with HOFBF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACHV jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-5.30%
HOFBF - ACHV
72%
Closely correlated
N/A
ALT - ACHV
56%
Loosely correlated
-1.99%
ABOS - ACHV
38%
Loosely correlated
-4.23%
RCKT - ACHV
36%
Loosely correlated
N/A
PLRX - ACHV
36%
Loosely correlated
-1.19%
More